Proteon logo     Print Page | Close Window

SEC Filings

S-1/A
PROTEON THERAPEUTICS INC filed this Form S-1/A on 10/07/2014
Entire Document
 

Exhibit 1.1

 

UNDERWRITING AGREEMENT

[Number of Firm Shares] Shares

Proteon Therapeutics, Inc.

Common Stock

 

UNDERWRITING AGREEMENT

 

 

[·], 2014

 

STIFEL, NICOLAUS & COMPANY, INCORPORATED

JMP SECURITIES, LLC

As representatives of the several Underwriters

named in Schedule I hereto

 

c/o                               Stifel, Nicolaus & Company, Incorporated

One South Street, 15th Floor

Baltimore, Maryland  21202

 

c/o                               JMP Securities, LLC

600 Montgomery Street, Suite 1100

San Francisco, CA  94111

 

Ladies and Gentlemen:

 

Proteon Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”), an aggregate of [·] shares (the “Firm Shares”) of the common stock, par value $0.001 per share, of the Company (“Common Stock”).  The Company also proposes to sell to the several Underwriters, for the sole purpose of covering over-allotments in connection with the sale of the Firm Shares, at the option of the Underwriters, up to an additional [·] shares of Common Stock (the “Option Shares”).  The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”.

 

The Company confirms as follows its agreements with the Representatives and the several other Underwriters.

 

1.                                      (a)                                 The Company represents and warrants to, and agrees with, each of the Underwriters that, as of the date hereof and as of the Closing Date (as hereinafter defined) and each Option Closing Date (as hereinafter defined), if any: